Conclusions: This analysis revealed no
evidence that varenicline is associated with
adverse neuropsychiatric events. The evidence
supports the superior efficacy of
varenicline relative to both placebo and
bupropion, indicating considerable benefit
without evidence of risk of serious neuropsychiatric
adverse events, in individuals
with and without a recent history of a
psychiatric disorder.